Publication | Closed Access

Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors

Medicinal ChemistryPharmaceutical ChemistryNatural SciencesMedicineIx InhibitorsOrganic ChemistryChemistryHeterocycle ChemistryPharmacologyHuman Carbonic AnhydraseSynthetic ChemistryDrug Discovery